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Abstract
Background: Although tissue-resident mesenchymal stromal cells (MSCs) in the larynx have been described, their
distinct characteristics and roles have not been thoroughly explored. Therefore, we investigated stem cell characteristics
and regenerative potentials of single clonal populations isolated from rat epiglottic mucosa (EM), lamina propria (LP),
and macula flava (MF) to determine whether they comprised laryngeal tissue-resident stem cells.
Methods: Single clonal laryngeal cells were isolated following microdissection of the EM, LP, and MF from the rat
larynx. Several clonal populations from the three laryngeal subsites were selected and expanded in vitro. We compared
the stem cell characteristics of self-renewal and differentiation potential, as well as the cell surface phenotypes and
gene expression profiles, of laryngeal MSC-like cells to that of bone marrow MSCs (BM-MSCs). We also investigated the
regenerative potential of the laryngeal cells in a radiation-induced laryngeal injury animal model.
Results: Self-renewing, clonal cell populations were obtained from rat EM, LP, and MF. EM-derived and LP-derived
clonal cells had fibroblast-like features, while MF-resident clonal cells had stellate cell morphology and lipid droplets
containing vitamin A. All laryngeal clonal cell populations had MSC-like cell surface marker expression (CD29, CD44,
CD73, and CD90) and the potential to differentiate into bone and cartilage cell lineages; EM-derived and MF-derived
cells, but not LP-derived cells, were also able to differentiate into adipocytes. Clonal cells isolated from the laryngeal
subsites exhibited differential extracellular matrix-related gene expression. We found that the mesenchymal and stellate
cell-related genes desmin and nestin were enriched in laryngeal MSC-like cells relative to BM-MSCs (P < 0.001). Growth
differentiation factor 3 (GDF3) and glial fibrillary acidic protein (GFAP) transcript and protein levels were higher in
MF-derived cells than in other laryngeal populations (P < 0.001). At 4 weeks after transplantation, laryngeal MF-derived
and EM-derived cells contributed to laryngeal epithelial and/or glandular regeneration in response to radiation injury.
Conclusions: These results suggest that cell populations with MSC characteristics reside in the EM, LP, and MF of the
larynx. Laryngeal MSC-like cells contribute to regeneration of the larynx following injury; further investigation is needed
to clarify the differential roles of the populations in laryngeal tissue regeneration, as well as the clinical implications for
the treatment of laryngeal disease.
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Background
Damage to vocal folds (VFs), which induces
disorganization of the layered ultrastructure of VFs,
often leads to severe dysphonia. During normal phon-
ation, the mucosal wave is vertically propagated by vi-
bration of epithelial mucosa overlying the superficial
lamina propria (LP) (Reinke’s space), which contains
extracellular matrix (ECM) proteins that confer visco-
elastic properties [1]. Changes in viscoelasticity due to
disruption of the arrangement of ECM proteins impact
voice quality. In many recent years, regenerative therap-
ies have been developed to either repair or reconstitute
ECM proteins by cell therapy, including transplant of ex-
ogenous stem cells or primary tissue-resident cells into
injured VFs. However, the biological functions of pri-
mary VF-resident cells in VF homeostasis and regener-
ation following injury have not been well characterized.
In order to establish the proof of concept for VF-derived
cell-based therapies, the roles of tissue-resident cells and
their mechanisms of action in VF must be elucidated.
The presence of a population of putative stem/pro-
genitor cells in the VFs has been suggested by the detec-
tion of label-retaining cells and side population cells [2–
4]. Mesenchymal stromal cell (MSC)-like cells have been
isolated from the epiglottic mucosa (EM) of the canine
larynx [5]. In addition, VF fibroblasts in the LP and stel-
late cells in the macula flava (MF) are tissue-resident
cells known to regulate ECM metabolism and maintain
VF homeostasis. Recently, multiple groups have assessed
the stem cell characteristics of human LP fibroblasts and
MF stellate cells, and proposed that they are VF-resident
stem/progenitor cells [6, 7]. Although several popula-
tions from laryngeal tissues have been characterized as
stem/progenitor cells, the exact localization of tissue-
specific stem cells and their comparative characteristics
have not yet been explored. Furthermore, cells obtained
by adherence to plastic generally contain mixed popula-
tions, preventing a definitive conclusion about the stem
cell characteristics of the populations. Purification of clonal
cells is important not only for stem cell characterization,
but also for the advancement of single-cell biology for
translation in future clinical applications. We previously re-
ported a subfractionation culture method that allowed us
to obtain homogeneous, clonal MSCs from bone marrow,
adipose tissue, and salivary glands [8–10]. In this study,
using the clonal cell culture method, we isolated several
self-renewing, clonal populations generated from single
cells from the EM, LP, and MF of rat larynges. We com-
pared their stem cell properties to those of representative
MSCs from bone marrow (BM-MSCs). These populations
all expressed MSC-like phenotypes and possessed the cap-
acity to undergo differentiation into mesenchymal lineage
cells. We then assessed the differential gene expression
profiles of laryngeal MSC-like cells and, for the first time,
found that expression of pluripotent stem cell marker,
growth differentiation factor 3 (GDF3), is a distinguishing
feature of MF-derived cells.
We also tried to further demonstrate that these specif-
ically isolated single clonal cells actually have an effect
on repairing and/or regenerating damaged laryngeal tis-
sue, by using an irradiation-induced fibrosis animal
model. Avoiding radiation exposure to the larynx is a
significant clinical problem for patients with head and
neck cancer, since irradiation-induced laryngeal fibrosis,
edema, and desiccated mucosa result in intractable dys-
phonia [11–13]. The use of MSCs as a treatment to pre-
vent or ameliorate damage associated with radiation may
be a useful approach. For these reasons, we employed
our previously established irradiation-induced laryngeal
dysfunction animal model to investigate regenerative po-
tential following radiation injury [13]. Results presented
herein will advance the understanding of laryngeal tissue
stem/progenitor cells, and serve as a prerequisite step
for development of clinical VF regenerative therapies.
Methods
Animal experiments
Female Sprague–Dawley (SD) rats (6 weeks of age, 180–
200 g) were purchased (Orient Bio, Gyeonggi-Do, Korea)
and acclimatized at 20–26 °C to a 12-hour light cycle for
1 week before use. The study was approved by the Ani-
mal Ethics Committee of Inha University Hospital (Per-
mit Number: INHA 141003-330-3). The regulations of
the Institutional Animal Care and Use Committee of the
Life Sciences Laboratory were followed for all animal ex-
perimental procedures. The minimum number of ani-
mals needed to achieve study objectives was chosen for
ethical and economic reasons.
The larynges of three SD rats were extracted and
folded out to expose the internal structures. Laryngeal
tissues were dissected from the EM, LP, and MF under a
stereo microscope (Olympus, Tokyo, Japan) (Fig. 1a).
EM tissue samples were obtained from the epiglottic
mucosa, and LP tissue samples were acquired from the
membranous VF. The MF is located at the anterior and
posterior end of the VF, which is connected to thyroid
cartilage (anterior MF) and arytenoid cartilage (posterior
MF). The precise location of the MF was also visualized
by Alcian blue (pH 2.5) staining (Fig. 1b). IMT i-
Solution software (IMT i-Solutions, Vancouver, BC,
Canada) was used for imaging, scanning, and processing.
Isolation of laryngeal tissue-resident clonal cells from
different laryngeal subsites
Each tissue sample was washed with 2% Antibiotic–
Antimycotic solution (Gibco BRL, Gaithersburg, MD,
USA) in Hank’s Balanced Salt Solution (HBSS; Gibco
BRL). Samples were then treated with 0.05% collagenase
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B (Roche, Mannheim, Germany) and DNase I (Roche)
for 1 hour at 37 °C. The enzymatic activity was stopped
by adding Dulbecco’s Modified Eagle Medium (DMEM;
Gibco BRL) containing 10% fetal bovine serum (FBS;
Gibco BRL) and 1% Antibiotic–Antimycotic. The super-
natant was removed by centrifugation at 470 rcf for 5 mi-
nutes, after which the pellet was resuspended in DMEM
containing 10% FBS and 1% Antibiotic–Antimycotic,
and then cultured at 37 °C under 5% CO2. When single
cell-derived colonies were formed, each colony was iso-
lated using a sterile 4.7 mm × 8 mm cloning cylinder
(Bel-Art Products, Wayne, NJ, USA) and then trans-
ferred to a six-well plate (Falcon, Thermo Fisher Scien-
tific, Waltham, MA, USA). The culture medium, low-
glucose (1 g/L) DMEM (L-DMEM; Gibco BRL) contain-
ing 10% FBS and 1% Antibiotic–Antimycotic, was chan-
ged every 2–3 days. The same lot number of FBS
products (Lot. No. 1831333; Gibco) was used for cell
cultures. Cells were split when they were 70–80%
confluent, and several clonal cells from the three la-
ryngeal subsites were selected and expanded in vitro.
A minimum of three clonal populations were estab-
lished from each subsite, and at least three different
clonal cells passaged fewer than 10 times were used
in our experiments.
Isolation of rat BM-MSCs
The femurs of SD rats were extracted and washed with
HBSS containing 2% Antibiotic–Antimycotic. The prox-
imal and distal areas of the femur were removed and the
marrow was extracted by injecting DMEM in the fem-
oral shaft. The extracted marrow was filtered through a
70-μm cell strainer (Falcon, Thermo Fisher Scientific)
and centrifuged at 470 rcf for 5 minutes. The super-
natant was removed and the pelleted bone marrow was
cultured in DMEM with 10% FBS and 1% Antibiotic–
Antimycotic at 37 °C under 5% CO2 for 24 hours. Float-
ing hematopoietic cells were washed away with phos-
phate buffered saline (PBS; Gibco BRL), after which the
medium was changed. Using sterile cloning cylinders,
single colonies were isolated and transferred to six-well
plates. The cells were cultured in L-DMEM containing
10% FBS and 1% Antibiotic–Antimycotic, which was
changed every 2–3 days. Cells were split when they
reached 70–80% confluency, and cells passaged fewer








Fig. 1 Location of laryngeal tissue-resident putative stem/progenitor cells. a Cross-sectional view of the rat larynx and the sites of dissection of
epiglottic laryngeal epiglottic mucosa (EM), vocal fold (VF), lamina propria (LP), and macula flava (MF). Scale bars, 50 μm (left); 20 μm (right).
b Alcian blue staining for identification of anterior (Ant. MF) and posterior MF (Post. MF) rat VFs. Scale bars, 50 μm. Whole larynx staining image
generated by stitching together 40× microscopic images
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Cell morphology and validation of MF stellate cells
We observed the morphology of the cells by phase-
contrast microscopy. To confirm that a cell isolated
from the MF was stellate, we assessed vitamin A autoflu-
orescence using the UV filter of an Axiovert 200
inverted fluorescence microscope (Carl Zeiss, Oberko-
chen, Germany), and then conducted retinoid-based
fluorescence-activated cell sorting (FACS). The cells
were sorted on a FACSAria cell sorter (BD Biosciences,
San Jose, CA, USA) using a 450/50-nm band-pass filter.
Immunofluorescence staining
The cells were seeded on glass coverslips (Marienfeld-
Superior, Baden-Württemberg, Germany) and cultured
for 24 hours, then fixed with 4% paraformaldehyde
(Wako, Osaka, Japan), washed with PBS, and perme-
abilized with 0.2% Triton X-100 (Sigma-Aldrich, St.
Louis, MO, USA). Blocking was conducted for 1 hour
using PBS containing 2% goat serum (Vector Laborator-
ies, Burlingame, CA, USA) and 1% bovine serum albu-
min. Samples were then incubated with antibodies
against vimentin (Cell Signaling Technology, Danvers,
MA, USA), α-smooth muscle actin (α-SMA; Millipore,
Darmstadt, Germany), glial fibrillary acidic protein
(GFAP; Abcam, Cambridge, UK), and growth differenti-
ation factor 3 (GDF3; Bioss, Woburn, MA, USA) at 4 °C
overnight, after which they were washed three times
with PBS. The samples were incubated with Alexa Fluor®
488-conjugated goat anti-rabbit and Alexa Fluor® 555-
conjugated goat anti-rabbit secondary antibodies (Invi-
trogen, Carlsbad, CA, USA) for 1 hour at 37 °C, after
which the cells were mounted with mounting solution
containing 4′,6-diamidino-2-phenylindole dihydrochlor-
ide (DAPI; Vector Laboratories).
Reverse transcription polymerase chain reaction and
quantitative real-time PCR
We extracted RNA from the isolated cells using TRIzol®
(Thermo Fisher Scientific), and then synthesized cDNA
using the RNA as a template with a Reverse Transcrip-
tion System Kit (Bioneer, Daejon, Korea) with incuba-
tions for 15 minutes at 37 °C, 5 seconds at 85 °C, and
10 minutes at 4 °C. PCR was conducted using gene-
specific primers for the synthesized cDNA. The amplifi-
cation step was repeated for 28 cycles consisting of
30 seconds of denaturation at 94 °C, 30 seconds of an-
nealing at 60 °C, and 30 seconds of extension at 72 °C.
After completion, the product was dyed with ethidium
bromide (Thermo Fisher Scientific) and subjected to gel
electrophoresis in 1.5% agarose.
The synthesized cDNA was included in PCR mixtures
with SYBR® Green Premix (Takara Bio, Shiga, Japan),
diethylpyrocarbonate-treated distilled water (Welgene,
Daegu, Korea), and gene-specific primers. The reactions
were conducted using a real-time PCR system (Applied
Biosystems, Carlsbad, CA, USA), as follows: 94 °C for
10 minutes, followed by 40 cycles of 95 °C for 10 sec-
onds, 55 °C for 25 seconds, and 72 °C for 30 seconds.
Each PCR amplification was performed in triplicate
wells. The results were normalized against those for the
reference gene glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH) by the 2–ΔΔCtt method, and results are
presented as the mean ± SD of real-time PCR triplicates.
The primer sequences are presented in Table 1.
Western blot analysis
Protein samples were isolated from cell lysates (50 μg),
and then mixed in reducing buffer, boiled, resolved by
sodium dodecyl sulfate (SDS)-polyacrylamide gel elec-
trophoresis, and transferred to a polyvinylidene difluor-
ide (PVDF) membrane by electroblotting. The blot was
incubated overnight at 4 °C in a blocking solution with
primary antibodies directed to the following antigens:
GFAP, peroxisome proliferator-activated receptor γ
(PPARγ), Wnt1 (Abcam, Cambridge, UK), growth dif-
ferentiation factor 3 (GDF3; Bioss, Woburn, MA,
USA), Smad2/Smad3, phospho-Smad2/Smad3 (Cell
Signaling Technology, Danvers, MA, USA), transform-
ing growth factor beta (TGF-β; Abcam, Cambridge,
UK), and β-actin (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). After the blots were washed with
0.1% Tween® 20 (Sigma-Aldrich) in 1 × PBS, they were
incubated with horseradish peroxidase-conjugated sec-
ondary antibodies corresponding to each primary anti-
body, then analyzed by enhanced chemiluminescence
detection (GE Healthcare Life Sciences, Pittsburgh, PA,
USA). Quantification of protein band intensities in
three independent experiments was performed, and the
relative ratio under the constant reference β-actin was
calculated.
Cell proliferation assay
For cell proliferation analysis, 2 × 104 cells were seeded
in a 100-mm culture dish. Cells were detached by treat-
ment with 0.05% trypsin/ethylenediaminetetraacetic acid
(Gibco BRL) every 3 days. Live cells were counted by the
trypan blue exclusion method, which utilizes characteris-
tics that have an intact cell membrane excluding certain
trypan blue dye. Briefly, a 10 μl mixture of cell sus-
pended in growth media and trypan blue solution was
inserted between the hemocytometer and the cover slip,
and the number of unstained cells was then counted.
We plotted cell proliferation based on the number of
live cells over 7–20 passages, and calculated the doub-
ling time. At least three independent experiments were
performed.
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Phenotypic analysis by flow cytometry
Cells isolated at passage 6 or 7 were resuspended in
PBS, and then incubated with antibodies conjugated to
fluorescein isothiocyanate (FITC) or phycoerythrin (PE)
at 4 °C for 30 minutes. Cells were analyzed using a
FACSCalibur system (BD Biosciences) and data were
analyzed using CellQuest™ (BD Biosciences). Dead cells
were excluded by forward scatter (FSC)/side scatter
(SSC) parameters, and viable cells were further gated as
a singlet population. Antibodies against CD29, CD90,
CD73, CD31, CD45, nestin (BD Biosciences), CD34,
CD105 (Abcam), and CD44 (R&D Systems, Minneapolis,
Table 1 Polymerase chain reaction primers
Primer Sequence 5′→ 3′
Alpha actin, α-actin (Acta1) Forward: ATTGGTATGGAGTCCCGACCG
Reverse: TCCCAGTGTAAGGTAGCCG
Alpha smooth muscle actin, α-SMA (Acta2) Forward: GAGAGGGATCCTGACCTGA
Reverse: CCACGCGAAGCTCGTTATAG
CD133 (Prom1) Forward: GGTCAGCCTGCATTCGCTAA
Reverse: CTGGACCACGTTGAGGAAGA
Desmin (Des) Forward: CAACCTTCCGCTCCAGACCT
Reverse: TCATGTTGTTGCTGTGTGGC
Epidermal growth factor (Egf) Forward: GCCAATGCTCAGAAGGCTAC
Reverse: CGTAAGTCTCGGTGCTGACA
Fibronectin (Fn) Forward: AGACTGCAGTGACCACCATCC
Reverse: CAATGTGTCCTTGAGAGCATAGAC
Glyceraldehyde-3-phosphate dehydrogenase (Gapdh) Forward: ATTCTACCCACGGCAAGTTCACTGG
Reverse: AGGGGCGGAGATGATGACCC
Growth differentiation factor 3 (Gdf3) Forward: TGCACTCTCTTCATGCCTCC
Reverse: GAACAGTTGGTGACGATGGC
Glial fibrillary acidic protein (Gfap) Forward: GCTCAATGACCGCTTTGCTA
Reverse: TCTGCCTGGTAAACGTCAGC
Hyaluronan synthase 2 (Has2) Forward: CCAATGCAGTTTCGGTGATG
Reverse: ACTTGGACCGAGCCGTGTAT
Hepatocyte growth factor (Hgf) Forward: TCGAGCTATCGCGGTAAAGA
Reverse: TGTGATCCATGGGACCTCTG
Nestin (Nes) Forward: TGCTGATGAGGAAGGAGCAG
Reverse: AAGCCTCATCCCAGAGACC
Peroxisome proliferator-activated receptor gamma (Pparg) Forward: TTCGGAATCAGCTCTGTGGA
Reverse: CCATTGGGTCAGCTCTTGTG
Tropoelastin (Eln) Forward: AGAAGCCTCGACATTAGATTTGGT
Reverse: GGAGCTATTCCCAGTGTGAGAAGT
Type I collagen (Col1a1) Forward: TTGACCCTAACCAAGGATGC
Reverse: CACCCCTTCTGCGTTGTATT
Vascular endothelial growth factor (Vegf) Forward: AGGCTGCACCCACGACAGAA
Reverse: CTGGAAGATGTCCAGGG
Vimentin (Vim) Forward: GCCTATGTGACCCGGT
Reverse: AGACGTGCCAGAAAGCATTGTCAA
von Willebrand factor (Vwf) Forward: TGCTCTTACGCCCATCTCT
Reverse: CACTCATACTCTGGGCAGCA
Wingless-type MMTV integration site family, member 1 (Wnt1) Forward: CGTGAACATAGCCTCCTCCA
Reverse: AATTGCCACTTGCACTCTCG
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MN, USA) were used in conjunction with appropriate
isotype controls (BD Biosciences). Isotype-matched con-
trol antibodies were used in each antibody analysis.
Multilineage differentiation
For adipogenic differentiation, 3 × 104 cells were seeded
in four-well plates (SPL, Gyeonggi-do, Korea) and incu-
bated for 48 hours, after which they were washed twice
with PBS and plated in adipocyte differentiation induc-
tion medium. The adipocyte differentiation induction
medium contained 10% FBS (Gibco BRL), 2% penicillin/
streptomycin (P/S; Gibco BRL), 10–7 M dexamethasone
(DEX; Sigma-Aldrich), 0.5 mM isobutylmethylxanthine
(Sigma-Aldrich), 10 μg/ml insulin (Sigma-Aldrich), and
100 or 200 μM indomethacin (Sigma-Aldrich) in high-
glucose DMEM (Gibco BRL). The medium was changed
every 2–3 days over the course of differentiation for 14
or 30 days. Differentiation was assessed by dyeing the
cells with Oil Red O (Sigma-Aldrich).
For osteogenic differentiation, 3 × 104 cells were seeded
in a collagen-coated (Roche) four-well plate and cultured
at 37 °C under 5% CO2. The osteogenic differentiation
medium contained 10% FBS, 2% P/S, 10–8 M DEX,
10 mM β-glycerolphosphate (Sigma-Aldrich), 50 μg/ml
ascorbic acid (Sigma-Aldrich), and 100 μM dibutyryl-
cyclic AMP (Sigma-Aldrich) in Minimum Essential
Medium Eagle, alpha modification (α-MEM; Welgene).
The medium was changed every 2–3 days for 21 days. We
dyed the cultures with 0.1% Alizarin Red S (pH 4.2)
(Sigma-Aldrich) to confirm calcium tubercle formation.
For chondrogenic differentiation, 2 × 105 cells were re-
suspended in a 15-ml conical tube and centrifuged at
840 rcf for 10 minutes. The samples were then cultured
at 37 °C under 5% CO2. The chondrogenic differenti-
ation induction medium contained 10% FBS, 2% P/S,
10–7 M DEX, 0.1% ITS premix (BD Bioscience), 50 μg/
ml ascorbic acid, 40 μg/ml L-proline (Sigma-Aldrich),
10 ng/ml transforming growth factor (TGF)-β1 (R&D
Systems), and 10 ng/ml TGF-β3 (R&D Systems) in α-
MEM. The medium was changed to chondrogenic dif-
ferentiation induction medium after 24 hours, and then
changed every 2–3 days for 21 days. Upon completion of
differentiation, pellets were embedded in optimum cut-
ting temperature (OCT) compound, after which the 8-
μm-thick frozen sections were dyed with Safranin O
(Thermo Fisher Scientific). Cells passaged fewer than
seven times were cultured individually and used for dif-
ferentiation induction.
In-vivo experiments
Irradiation and transplantation of EM, LP, and MF clonal cells
Twenty-five SD rats (6 weeks old, 150–200 g) were ran-
domly divided into five groups (n = 5 per group) as fol-
lows: normal control (Normal), RT control (RT + Vehicle
group), EM cell injection after irradiation (RT + EM
group), LP cell injection after irradiation (RT + LP
group), and MF cell injection after irradiation (RT +MF
group). The rats locally irradiated in the laryngeal re-
gion, while the rest of the body was shielded from radi-
ation. Prior to irradiation, rats were anesthetized using
xylazine (10 mg/kg) and ketamine (110 mg/kg). Animals
were firmly fixed in a plastic mold and irradiated with a
9-MeV electron beam from a linear accelerator (Clinac®
iX; Varian Medical System, Palo Alto, CA, USA) using a
single dose of 15 Gy. Rats that did not receive irradiation
served as the control group.
After 4 weeks of irradiation, rats were anesthetized
and the larynx was exposed using a custom-made laryn-
goscope and a surgical operating microscope (Carl Zeiss,
Welwyn Garden City, UK). Vehicle or EM, LP, or MF
cells labeled with the red fluorescent dye PKH26
(Sigma-Aldrich) were injected (1 × 105 in 10 μl of PBS)
into the unilateral VFs of the rats using a syringe with a
25-gauge needle.
Histological and immunofluorescence examination
At 4 weeks after transplantation, the larynges were re-
moved post euthanasia for detection of the red
fluorescent-labeled EM-derived, LP-derived, and MF-
derived cells transplanted into irradiated rat VFs. The la-
rynges were fixed with 4% paraformaldehyde, embedded
in OCT compound (Sakura Finetek USA), and cut into
7-μm-thick sections. The slides were washed in PBS and
stained with DAPI (Invitrogen) for 3–5 minutes to stain
the cell nuclei. The slides were visualized using a con-
focal laser scanning microscope (Olympus).
For evaluation of histological changes, larynges were
fixed and paraffin-embedded, and then sectioned into 4-
μm slices. The sections were stained with hematoxylin
and eosin (HE) and Masson’s trichrome (MTC), using
standard pathology department protocols. For immuno-
fluorescence, paraffin sections were deparaffinized in xy-
lene, rehydrated in ethanol, and washed with PBS.
Nonspecific binding was blocked with PBS containing
1% bovine serum albumin. Slides were incubated with
primary antibodies for collagen type I (ABBiotec, San
Diego, CA, USA), E-cadherin (R&D Systems), and
aquaporin 4 (AQP4) and aquaporin 5 (AQP5) (Santa
Cruz Biotechnology, CA, USA) overnight at 4 °C. After
washing in PBS, slides were incubated with Alexa
Fluor® 488-conjugated anti-rabbit IgG (Invitrogen),
anti-goat secondary antibodies (Invitrogen), and Alexa
Fluor® 594-conjugated anti-mouse and anti-goat sec-
ondary antibodies (Invitrogen) for 1 hour in the dark at
20–25 °C. The nuclei were counterstained with DAPI
(Vector Labs) and then the slides were viewed using a
confocal laser scanning microscope (Olympus). Fluor-
escence intensity was measured using ImageJ software.
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Statistics
Statistical analysis was conducted using the GraphPad
Prism 5 package (GraphPad Software, La Jolla, CA,
USA). One-way analysis of variance (ANOVA) and
Tukey’s post-hoc test were used to determine intergroup
differences. Differences of P < 0.05 were considered sta-
tistically significant.
Results
Isolation of laryngeal tissue-resident clonal cells from rat
larynx
We employed the single clonal cell culture method to
isolate several single clonal cells from microscopically
dissected EM from larynges, and LP and MF from VFs,
in three rats. After enrichment of clonal cells, at least
three subpopulations isolated from various sites were
selected and characterized. During subculture, the
clonal cells isolated from the EM and LP had a spindle-
shaped fibroblast-like appearance; however, clonal cells
from the MF had a distinct star-like appearance
(Fig. 2a). Immunofluorescence staining revealed that all
clonal cells expressed the mesenchymal cell markers
vimentin and α-SMA (Fig. 2a). RT-PCR confirmed that
all clonal cells were purified mesenchymal cells that
lacked epithelial (Krt19) or endothelial (Vwf ) gene ex-
pression (Fig. 2b).
MF stellate cells were validated using a phase-contrast
microscope. We found lipid droplets in the cytoplasm of
clonal MF cells, which were absent in LP-derived and
EM-derived cells (Fig. 2a, c). We also observed vitamin
A autofluorescence in clonally expanded MF cells
(Fig. 2d). We further confirmed vitamin A storage in sin-
gle clonal MF cells by retinoid-based FACS sorting
(Fig. 2e).
Self-renewal capacity of laryngeal tissue-resident clonal cells
The self-renewal properties of laryngeal-resident clonal




Fig. 2 Isolation and validation of laryngeal tissue-resident clonal cells. a Clonal cells purified from laryngeal subsites of EM, LP and MF visualized
by phase-contrast microscopy. Scale bars, 100 and 20 μm. Representative immunofluorescence staining images of laryngeal clonal cells expressing
mesenchymal markers vimentin and α-SMA. b Expression of the genes Krt19 (epithelial cell marker) and Vwf (endothelial cell marker) was not
detected, whereas that of Vim and Acta2 was detected in all laryngeal clonal cells. c MF stellate cells were validated to contain lipid droplets (arrow)
by phase-contrast microscopy. Scale bars, 25 μm. These cells demonstrated vitamin A (retinoid) autofluorescence as assessed by d fluorescence
microscopy (scale bars, 10 μm) and e retinoid-based FACS sorting. EM epiglottic mucosa, LP lamina propria, MF macula flava, α-SMA α-smooth
muscle actin, FSC forward scatter
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proliferative activity. We cultured three clonal popula-
tions derived from the EM, LP, and MF up to passage 20
without obvious morphological changes during cultiva-
tion. We determined the rate of cell proliferation by
calculating the doubling time during subculture. The
population doubling time was 31.2, 45.6, and 36 hours
for cells from the EM, LP, and MF, respectively
(Fig. 3a). These results suggest that the isolated clonal
populations are highly proliferative rather than dor-
mant or quiescent.
Characterization of MSC properties
MSC surface marker analysis
We performed flow cytometry to compare laryngeal MSC
surface marker expression with BM-MSC marker expres-
sion. Laryngeal clonal cells expressed MSC markers such
as CD29, CD44, CD73, and CD90, in the absence of ex-
pression of hematopoietic markers such as CD31, CD34,
and CD45 (Fig. 3b). The MSC marker CD105 (endoglin)
was not detected in laryngeal cells, although it was de-
tected in BM-MSCs. In addition, nestin, a marker of un-
differentiated stem cells, was observed in laryngeal clonal
cells.
Mesenchymal lineage differentiation potential
To determine their mesenchymal differentiation potential,
we examined the ability of clonal cells to differentiate into
adipogenic, osteogenic, and chondrogenic lineages upon
appropriate induction (Fig. 4a). We cultured clonal cells in
adipocyte differentiation-inducing media; both BM-MSCs
and EM-derived clonal cells differentiated into adipocytes
containing lipid vacuoles that stained with Oil Red O,
a
b
Fig. 3 Clonal cell growth and surface marker expression profiles of laryngeal clonal cells. a Laryngeal tissue-resident cells from EM, LP, and MF
displayed high proliferative activities up to passage 20, with doubling times (DT) of 31.2, 45.6, and 36 hours, respectively. b Flow cytometric
analysis revealed that all laryngeal clonal cells expressed MSC markers CD29, CD44, CD73, and CD90, in the absence of CD105, CD31, CD34, and
CD45. In addition, they were positive for nestin, a marker of undifferentiated stem cells. Experiments were performed in three biological replicates
(at least three clonal populations) with similar results (data not shown). EM epiglottic mucosa, LP lamina propria, MF macula flava, BM bone marrow
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while LP-derived and MF-derived clonal cells did not.
However, when we increased the dose of indomethacin in
the adipogenic differentiation medium to 200 μM, MF-
derived cells, but not LP-derived cells, were induced to
differentiate into adipocytes (Fig. 4a).
We performed Alizarin Red S staining to assess the
formation of mineralized nodules in the osteogenic dif-
ferentiation cultures. All laryngeal clonal cells and BM-
MSCs differentiated and formed mineralized nodules
after 21 days of osteogenic differentiation induction
a
b c
Fig. 4 Differentiation potential into mesenchymal lineage cells. a Potential of clonal cells to differentiate into adipogenic, osteogenic, and chondrogenic
lineage cells analyzed via lineage-specific cytochemical staining. Adipogenic differentiation was assessed by Oil Red O staining of intracellular lipid
vacuoles. Indomethacin was added to induce adipogenic differentiation of MF cells. Scale bars, 50 μm. Osteogenic differentiation was assessed
by Alizarin Red S staining of mineralized nodules. Scale bars, 100 μm. Chondrogenic differentiation was assessed by Safranin O staining of
proteoglycans. Scale bars, 25 μm. Levels of PPARγ and Wnt1, which were related to the plasticity of laryngeal clonal cells, confirmed by b qRT-PCR
and c Western blot analysis. Error bars, SD (n = 3 wells). *P < 0.05, ***P < 0.001 compared with BM-MSCs; ##P < 0.01, ###P < 0.001 compared with EM cells;
$$P < 0.01 compared with LP cells. Refer to Additional file 1 for complete statistical values. EM epiglottic mucosa, LP lamina propria, MF macula flava,
BM bone marrow
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(Fig. 4a). Under chondrogenic differentiation conditions,
all laryngeal clonal cells and BM-MSCs differentiated
into chondrocytes (Fig. 4a). We confirmed the formation
of proteoglycan using Safranin O dye 21 days after in-
duction. Taken together, these data indicate that all la-
ryngeal clonal cells possess MSC characteristics.
Role of Wnt signaling in laryngeal MSC-like cell plasticity
In addition, we explored the involvement of Wnt signals
in the adipogenic differentiation potential of laryngeal
MSC-like cells. We detected significantly higher Wnt1
mRNA and protein levels in LP and MF-derived cells
compared to BM-MSCs and EM-derived cells, and lower
PPARγ levels compared to BM-MSCs (Fig. 4b, c). These
results suggest that Wnt signaling may regulate laryngeal
MSC-like cell plasticity in undifferentiated LP-derived
and MF-derived cells through inhibition of PPARγ ex-
pression. For more details of the statistical analysis, refer
to Additional file 1.
Molecular characteristics and biological functions of
laryngeal-resident stem cells
We next performed qRT-PCR to further investigate the
molecular characteristics of laryngeal-resident MSC-like
cells and their potential biological roles in ECM regula-
tion. We analyzed the relative mRNA levels of the stel-
late or stem cell markers desmin, nestin, GFAP, GDF3,
neural cell adhesion molecule (NCAM), nerve growth
factor (NGF), and CD133 (Prom1); the ECM-related
markers collagen I, elastin, fibronectin, and hyaluronic
acid; and the growth factors hepatocyte growth factor
(HGF), epidermal growth factor (EGF), and vascular
endothelial growth factor (VEGF) (Fig. 5).
We quantitatively analyzed the expression levels of
stellate cell-related markers (Fig. 5a and Additional file
1). Laryngeal clonal cells expressed higher levels of des-
min (Des) and nestin (Nes) than BM-MSCs. Within the
laryngeal clonal MSC-like cell populations, the expres-
sion levels of Des and Nes were highest in LP-derived
cells. The mRNA level of Gdf3 was significantly higher
in MF-derived cells than in other laryngeal clonal cells
and BM-MSCs. Although we did not detect a statistical
difference in Gfap mRNA expression in laryngeal MSC-
like cells and BM-MSCs, the levels of Gdf3 were higher
in MF-derived cells than LP-derived cells, indicating
GFAP and GDF3 may be distinguishing markers of MF-
derived cells (Fig. 5b, c). However, NCAM (Ncam), NGF
(Ngf ), and CD133 (Prom1) gene expression was lower in
MF-derived cells compared to BM-MSCs and EM cells.
We detected downregulation of the ECM genes
Col1a1 (collagen I) in all laryngeal MSC-like cells and
Has2 (HA synthase) in MF-derived cells, while Eln (elas-
tin) and Fn1 (fibronectin) were upregulated in EM-
derived and MF-derived cells relative to BM-MSCs
(Fig. 5d and Additional file 1). EM-derived cells
expressed a much higher level of Eln, while the MF-
derived cells had much lower Has2 expression, than
other laryngeal MSC-like cells. The mRNA level of Hgf
was elevated in the LP-derived and MF-derived cells
relative to BM-MSCs and EM-derived cells. MF-derived
cells exhibited a higher level of EGF than other laryngeal
MSC-like cells. All laryngeal resident MSC-like cells
showed decreased levels of VEGF.
Regenerative potential of laryngeal clonal stem cells
To determine whether laryngeal clonal MSC-like cells
possessed regenerative potential, we transplanted them
into the VFs of rats following radiation damage to the
larynx. We performed histological evaluations of ECM
production, as well as epithelial regeneration and laryn-
geal hydration. We observed a few PKH26-labeled EM-
derived, LP-derived, and MF-derived cells at the site of
injection in rat larynges 4 weeks post transplantation.
Histological analysis of HE and MTC staining revealed
that the epithelial thickening and subepithelial fibrosis
that occurred after irradiation were alleviated in the
groups transplanted with EM-derived and MF-derived
cells (Fig. 6a). The expression of TGF-β1 and phosphor-
ylated SMAD2/3 (p-SMAD2/3) in rat VFs after trans-
plantation of laryngeal clonal MSC-like cells was
attenuated, while laryngeal irradiation led to a significant
upregulation of p-Smad2/3 and TGFβ1 (Fig. 6b and
Additional file 1).
Immunofluorescence analysis of VFs revealed in-
creased production of collagen I in the irradiated and ve-
hicle (PBS)-injected VFs, which was not reduced in all
treated VFs. Expression of the epithelial junctional ad-
herence marker E-cadherin was increased in the Vehicle
group, suggesting thickening of the epithelium compared
to the nonirradiated control group. In the groups trans-
planted with EM-derived and MF-derived cells, but not
LP-derived cells, the epithelial thickening was signifi-
cantly alleviated. After irradiation, the expression of
aquaporins (AQPs), which are involved in VF epithe-
lial hydration and lubrication, was decreased in VFs
(AQP4) and laryngeal glands (AQP5). The expression
of AQP5 was significantly restored after MF cell in-
jection and, although the trend was not significant,
the expression of AQP4 was also increased (Fig. 7
and Additional file 1).
Discussion
We isolated clonal populations from different laryngeal
subsites, including the EM of the larynges, and the LP
and MF of the VFs, and demonstrated that these clonal
cells represent laryngeal tissue-resident MSC-like cells.
These highly proliferating clonal populations maintained
their MSC surface marker expression and their potential
Lee et al. Stem Cell Research & Therapy  (2017) 8:200 Page 10 of 16
to differentiate into mesenchymal lineage cells during
cultivation in vitro. These results support the existence
of laryngeal tissue-resident cells, such as VF fibroblasts
and MF stellate cells, that share MSC properties and
may participate in repopulation of laryngeal cells or con-
tribute to laryngeal homeostasis; it is not yet clear how
many populations are present in the quiescent state or
how they are influenced by microenvironmental injury
to participate in the regenerative process.
Laryngeal tissue-resident stem/progenitor cells are
promising candidates for cell-based regenerative medicine
to improve various voice disorders induced by scarring,
radiation damage, or senescence. The nomenclature for
VF-resident cells has been determined by cell morphology.
Fibroblast-like cells in the LP and star-like cells in the MF
have been named VF fibroblasts and MF stellate cells, re-
spectively. Recent studies have shown that activated VF fi-




Fig. 5 Molecular characteristics and biological functions of laryngeal clonal cells. a Gene expression of stellate cell markers Des, Nes, Gfap, Gdf3,
Ncam, Ngf, and Prom1 analyzed by qRT-PCR. Error bars, SD (n = 3 wells). *P < 0.05, **P < 0.01, ***P < 0.001 compared with BM-MSCs; #P < 0.05,
###P < 0.001 compared with EM cells; $P < 0.05, $$P < 0.01, $$$P < 0.001 compared with LP cells. b Immunofluorescent staining was performed
to identify differential markers of MF cells, GFAP and GDF3. Scale bars, 20 μm. c Protein expression of GFAP and GDF3 confirmed by western
blot analysis. d Expression of ECM-related genes (Col1a1, Eln, Fn, and Has2) and growth factors (Hgf, Egf, and Vegf) analyzed in clonally expanded
laryngeal MSC-like cells by qRT-PCR. Error bars, SD (n = 3 wells). *P < 0.05, **P < 0.01, ***P < 0.001 compared with BM-MSCs; #P < 0.05, ##P < 0.01,
###P < 0.001 compared with EM cells; $P < 0.05, $$$P < 0.001 compared with LP cells. Refer to Additional file 1 for complete statistical values.
EM epiglottic mucosa, LP lamina propria, MF macula flava, BM bone marrow
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scarring through ECM modulation [14, 15]. Another re-
cent study by Thibeault et al. suggested that VF fibroblasts
are MSCs which reside in the LP of VFs [6]. In addition,
the paracrine release of inflammatory cytokines or ECM-
regulating proteins by VF fibroblasts supports their poten-
tial therapeutic role in VF remodeling [16–18]. Another
population of VF-resident cells in the MF (MF stellate
cells) has long been known to be involved in the metabol-
ism of the ECM of VFs [19–21]. Sato et al. [7] recently
evaluated the characteristics of MF stellate cells and pro-
posed that they are MSCs residing in the stem cell niche-
like MF.
Although stem cell characteristics of laryngeal-resident
cells have been investigated, biological functions of
tissue-resident stem/progenitor cells from different
sources in laryngeal regeneration and tissue homeostasis
are still not well understood. In this study, we isolated
single clonal cells from three different subsites to
explore the stem cell characteristics of laryngeal tissue-
specific stem/progenitor cells, using our method of sub-
fractionation culture to enable isolation of single clone-
derived homogeneous stem cell populations [10]. When
compared with BM-MSCs, our results revealed that VF
fibroblasts, MF stellate cells, and EM fibroblasts all dis-
play self-renewal capacity and multipotent stem cell fea-
tures consistent with the presence of laryngeal tissue-
resident MSC-like cells. Immunophenotypic analysis by
flow cytometry demonstrated that the clonal cells from
a
b
Fig. 6 Engraftment of transplanted laryngeal clonal cells and their roles in irradiation-induced fibrosis or inflammation. a Red fluorescent dye PKH26-
labeled laryngeal MSCs were observed in the irradiated VF site. Representative image of HE staining and MTC staining at 4 weeks post transplantation.
At least three random tissue sections per VF from five rats were chosen for evaluation. Scale bars, 20 or 50 μm. b Western blot analysis was performed
to detect expression of TGF-β1, SMAD2/3, and p-SMAD2/3 in rat VFs. Data representative of three independent experiments. One-way ANOVA, Tukey’s
post-hoc test. ***P < 0.001 vs Normal; ###P < 0.001 vs Vehicle. Refer to Additional file 1 for complete statistical values. MSC mesenchymal stromal cells,
VF vocal fold, RT radiation, EM epiglottic mucosa, LP lamina propria, MF macula flava
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the three subsites expressed MSC surface markers
CD29, CD44, CD73, and CD90, but not CD31, CD34,
and CD45, similar to BM-MSCs. The expression of
CD105 was not observed on laryngeal cells. Although
Dominici et al. [22] proposed “standard criteria” for de-
fining MSCs, the criteria do not include all sources of
MSCs. MSC-like cells, which share MSC characteristics
but are distinct in their surface marker expression and
differentiation, have been isolated from various sources
[23]. For example, CD105 expression has been reported
to be variable and occasionally absent in tissue-resident
or circulating MSCs [23, 24]. In addition, we observed
synthesis of nestin, which is elevated during activation of
somatic stem cells, in laryngeal clonal cells, suggesting
that these clonal cells represent undifferentiated stem/
progenitor cells [25]. Similar to BM-MSCs, laryngeal
clonal cells possessed multipotent mesodermal differenti-
ation capacity. Collectively, the laryngeal clonal cells iso-
lated from rat EM, LP, and MF possessed MSC-like
properties, but it remains to be determined whether these
clonal populations represent distinct MSC subpopulations.
We observed plasticity in the potential of laryngeal
MSC-like cells to differentiate into adipocytes and osteo-
blasts. LP-derived and MF-derived cells had lower adipo-
cyte differentiation potential than BM-MSCs, but better
osteoblast differentiation potential. This difference may
be related to differential Wnt signaling in the subsets.
Wnt is known to inhibit differentiation into adipocytes
and induce differentiation into osteoblasts [26]. Analysis
of gene expression revealed that Wnt1 gene expression
levels were significantly higher in LP-derived and MF-
derived cells than in EM-derived cells and BM-MSCs.
Wnt1 inhibits adipocyte differentiation by suppressing
expression of PPARγ [27]. LP-derived and MF-derived
cells with high levels of Wnt1 also had very low expres-
sion of PPARγ, which is essential for adipogenesis and
the induction of lipid production [28]. MF-derived cells,
which had relatively low Wnt1 expression compared to
LP cells, could be induced to differentiate into adipo-
cytes in media containing twice the standard concentra-
tion of indomethacin. Indomethacin induces adipocyte
differentiation by inhibiting Wnt/β-catenin signaling
Fig. 7 Laryngeal regeneration after transplantation of laryngeal clonal cells following radiation damage. Immunofluorescent staining for collagen I,
E-cadherin, AQP4, and AQP5 performed on irradiated rat VFs. At least three random tissue sections per VF from five rats were chosen for evaluation. Scale bars,
20 μm. Fluorescence intensity and epithelial thickness measured using ImageJ. Error bars, SD (n = 5 animals). One-way ANOVA, Tukey’s post-hoc test.
*P < 0.05, **P < 0.01, ***P < 0.001 vs Normal; ##P < 0.01, ###P < 0.001 vs Vehicle; $$$P < 0.001 vs EM; †P < 0.05, ††P < 0.01 vs LP. Refer to Additional file 1 for
complete statistical values. RT radiation, EM epiglottic mucosa, LP lamina propria, MF macula flava, COL1 collagen I, E-cad Ecadherin, AQP aquaporin
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[29]. These results demonstrate that the expression of
Wnt affects the differentiation potential of laryngeal
MSC-like cells.
In this study, we isolated MF stellate cells from rat
VFs. Stellate cells have been shown to exist in human
liver, pancreas, lungs, kidneys, spleen, and ovaries. They
are generally star-shaped, but may show various morph-
ologies depending on their location and activation status
[30, 31]. Stellate cell activation is associated with loss of
cytoplasmic vitamin A (retinol) stores, and detection of
vitamin A in lipid droplets has been widely applied to
validate the identity of stellate cells [32]. Furthermore,
their specific autofluorescence can be used for stellate
cell separation and purification. In this study, we per-
formed retinol-based FACS to assess whether isolated
MF cells are stellate cells containing vitamin A.
Stellate cells are known to express various intermediate
filaments, including desmin and GFAP, as well as the
neural stem cell marker nestin. In addition, neurotrophins,
such as NGF and NCAM, and the liver stem/progenitor
cell marker CD133 (Prom1) have been reported to be stel-
late cell markers [33, 34]. However, in this study, the
mRNA levels of desmin, nestin, NGF, and CD133 were
highest in LP-derived cells among all laryngeal clonal pop-
ulations. GFAP gene expression was only elevated in MF
cells compared to other laryngeal clonal cells, although it
was not significantly different from expression in BM-
MSCs. These results suggest that the existing stellate cell-
related markers cannot be applied uniformly to laryngeal
stem cells, especially MF stellate cells. To identify another
specific marker of MF-derived cells, we searched for pro-
teins highly expressed in preadipocytes, based on the fact
that stellate cells, like preadipocytes, contain lipid drop-
lets. We found that expression of the pluripotent stem cell
gene GDF3, which inhibits adipocyte development and is
highly expressed in preadipocytes [35, 36], was highly
expressed in MF-derived cells compared to BM-MSCs
and other laryngeal MSC-like cells. We also observed ro-
bust GDF3 protein expression in MF-derived cells
through immunofluorescence staining and western blot
analysis. Taken together, such findings suggest that GDF3
can be used as a new marker for MF stellate cells, allowing
MF-derived cells to be distinguished from other laryngeal
MSC-like cells. Further investigations are warranted to
better understand the behavior of human laryngeal stem
cells, although we have found that human LP-derived or
MF-derived cells show similar phenotypic expression (data
not shown).
Various growth factors and cytokines secreted by stem
cells play important roles in tissue repair; thus, under-
standing the mechanism of ECM modulation is import-
ant [37, 38]. In this study, we compared the ECM
expression characteristics of laryngeal clonal MSC-like
cells with those of BM-MSCs, which have been widely
used for tissue engineering [39, 40]. When compared to
BM-MSCs, LP-derived and MF-derived cells had signifi-
cantly higher expression of HGF, a factor that promotes
wound healing, inhibits collagen deposition, reduces scar
formation, and prevents fibrosis [41]. MF-derived cells
expressed high levels of EGF mRNA relative to other la-
ryngeal MSC-like cells and BM-MSCs. EGF promotes
cell growth, differentiation, and division, and quickly re-
pairs damage in epithelial tissues [42]. These findings
suggest that LP-derived cells and MF-derived cells may
be more closely related to ECM regulation in LP and
epithelial regeneration of VFs, respectively. Interestingly,
all laryngeal MSC-like cells expressed low levels of
VEGF, which may be attributed to the scant vascular
structure of VFs [43].
The mRNA levels of Col1a1 in laryngeal MSC-like
cells and Has2 in MF cells were 0.5 times lower than in
BM-MSCs. However, fibronectin and elastin were more
highly expressed in laryngeal MSC-like cells than in BM-
MSCs. In addition, tropoelastin expression was more
than 1500 times higher in all laryngeal clonal MSC-like
cells than in BM-MSCs. Further investigation into ECM
synthesis by laryngeal clonal MSC-like cells is required
to enable the development of cell therapies for larynx re-
pair and function recovery. The synthesis of various cy-
tokines and growth factors by laryngeal MSC-like cells,
as well as their interaction with innate neighboring cells,
may be essential to their contribution to the wound
healing process.
In this study, PKH26-labeled laryngeal MSCs appeared
to be distributed in the irradiated VFs for up to 1 month
after allogeneic transplantation. The survival of laryngeal
MSCs in the injured VFs was probably related to the
characteristics of MSCs, as well as tissue properties of
VF [44]. MSCs have immunosuppressive features by
themselves, which allow transplanted allogeneic MSCs
to survive in recipient tissues. Nevertheless, an auto-
transplantation model using autologous MSCs for im-
plantation into damaged VF may provide better results
on VF regeneration following injury. Moreover, the
number of tissue samples might be insufficient to obtain
adequate statistical power, and additional investigations
are required to confirm our speculations.
MF-derived cells contributed to laryngeal epithelial
and glandular regeneration following radiation injury,
but LP-derived cells were unable to remodel the VF after
radiation in rats. In addition, EM-derived cells possessed
regenerative potential for laryngeal epithelium, but they
did not affect the level of AQP expression in the epithe-
lium or laryngeal glands. Other stellate cell systems in
the liver and pancreas have been suggested to be tissue
stem cells that contribute to regeneration of injured or-
gans through differentiation [45, 46]. In addition to
tissue-resident stem cells, alternative cell sources for cell
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therapy, including migrating or transplanted MSCs from
other organs (e.g., BM or adipose tissue), have been
studied to determine whether they contribute to VF re-
generation after injury, either by differentiation into VF-
resident cells or by paracrine secretion of factors [44, 47,
48]. Although we did not track the cells from bone mar-
row to home into injured VFs, the current literature sug-
gests that MSC-like cells, regardless of cell source, may
promote VF wound repair or regeneration.
Conclusions
In summary, we isolated and characterized laryngeal
tissue-resident clonal cells from the EM, LP, and MF of
rat larynges. The laryngeal cells possessed self-renewal
and MSC surface marker expression, and the capacity to
differentiate into mesenchymal lineage cells. The expres-
sion of markers such as desmin, nestin, GDF3, and
GFAP varied with cell type. The synthesis of growth fac-
tors such as HGF and EGF indicated that the cells may
have ECM-regulating biological functions. We also
found that laryngeal MSC-like cells may play a crucial
role in laryngeal regeneration, although further investi-
gation is required to unveil the biological roles of laryn-
geal MSC-like cells in development and homeostasis of
tissues.
Additional file
Additional file 1: Statistical data on relevant means and standard
deviations thoughout the experiment. (XLSX 14 kb)
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